Objective:

To address specific concerns regarding the proposed 2026 ASC rule, including its financial implications and potential impact on patient care in ophthalmology.

Key Findings:

• Proposed cuts to cataract facility fees do not reflect rising operational costs for ASCs, potentially compromising patient care.
• ASCs receive about 50% of the payments that hospital outpatients receive for similar services, raising concerns about equity in healthcare.
• Continued reductions could lead to a decline in quality of care and a shift of services back to hospitals, which may be more costly for patients.

Interpretation:

The proposed ASC rule fails to acknowledge the financial realities faced by ASCs, potentially jeopardizing patient care and service delivery, as evidenced by the increasing operational costs and the risk of service migration back to hospitals.

Limitations:

• The article does not provide specific data on the extent of operational cost increases, limiting the understanding of the financial impact.
• Limited information on the potential long-term impacts of the proposed rule on patient outcomes, including quality of care and access to services.
• Lack of stakeholder perspectives on the proposed rule, which could provide a more comprehensive view of its implications.

Conclusion:

OOSS is committed to advocating for fair reimbursement rates for ASCs to ensure high-quality ophthalmic care for Medicare patients.